These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16501733)

  • 1. Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage.
    Boerma JT; Stanecki KA; Newell ML; Luo C; Beusenberg M; Garnett GP; Little K; Calleja JG; Crowley S; Kim JY; Zaniewski E; Walker N; Stover J; Ghys PD
    Bull World Health Organ; 2006 Feb; 84(2):145-50. PubMed ID: 16501733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of antiretroviral therapy coverage: methodology and trends.
    Mahy M; Tassie JM; Ghys PD; Stover J; Beusenberg M; Akwara P; Souteyrand Y
    Curr Opin HIV AIDS; 2010 Jan; 5(1):97-102. PubMed ID: 20046154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.
    Dutta A; Barker C; Kallarakal A
    PLoS Med; 2015 Nov; 12(11):e1001907; discussion e1001907. PubMed ID: 26599990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human resources for treating HIV/AIDS: needs, capacities, and gaps.
    Bärnighausen T; Bloom DE; Humair S
    AIDS Patient Care STDS; 2007 Nov; 21(11):799-812. PubMed ID: 17944556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Height and Weight Changes in Children Using Cotrimoxazole Prophylaxis With Antiretroviral Therapy.
    Boettiger DC; Muktiarti D; Kurniati N; Truong KH; Saghayam S; Ly PS; Hansudewechakul R; Van Nguyen L; Do VC; Sudjaritruk T; Lumbiganon P; Chokephaibulkit K; Bunupuradah T; Nik Yusoff NK; Wati DK; Mohd Razali KA; Fong MS; Nallusamy RA; Sohn AH; Kariminia A;
    Clin Infect Dis; 2016 Nov; 63(9):1236-1244. PubMed ID: 27470239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost?
    Gutierrez JP; Johns B; Adam T; Bertozzi SM; Edejer TT; Greener R; Hankins C; Evans DB
    Lancet; 2004 Jul 3-9; 364(9428):63-4. PubMed ID: 15234857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of HIV/AIDS clinical care quality: the case of a referral hospital in North West Ethiopia.
    Alemayehu YK; Bushen OY; Muluneh AT
    Int J Qual Health Care; 2009 Oct; 21(5):356-62. PubMed ID: 19684032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of people on antiretroviral treatment in Zambia: a retrospective cohort analysis of HIV clients on ART.
    Amanzi P; Michelo C; Simoonga C; Dambe R; Chongwe G
    Pan Afr Med J; 2016; 24():144. PubMed ID: 27642482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-level impact of an accelerated HIV response plan to reach the UNAIDS 90-90-90 target in Côte d'Ivoire: Insights from mathematical modeling.
    Maheu-Giroux M; Vesga JF; Diabaté S; Alary M; Baral S; Diouf D; Abo K; Boily MC
    PLoS Med; 2017 Jun; 14(6):e1002321. PubMed ID: 28617810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the Influence of Socioeconomic Environment on Paediatric Antiretroviral Treatment Coverage: Towards Closing Treatment Gaps in Sub-Saharan Africa.
    Adeyinka DA; Evans MR; Ozigbu CE; van Woerden H; Adeyinka EF; Oladimeji O; Aimakhu C; Odoh D; Chamla D
    Cent Eur J Public Health; 2017 Mar; 25(1):55-63. PubMed ID: 28399356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the "Treating 3 million by 2005. Making it happen. The WHO strategy" ("3 by 5").
    Aceijas C; Oppenheimer E; Stimson GV; Ashcroft RE; Matic S; Hickman M
    Addiction; 2006 Sep; 101(9):1246-53. PubMed ID: 16911723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of collaboration in the TB and HIV control programme in Oromia Region, Ethiopia: Seven years of retrospective data.
    Sisay S; Mekonen A; Abera A; Berhan Y; Kebede T; Ferede A
    Int J Infect Dis; 2018 Dec; 77():74-81. PubMed ID: 30336266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scaling-up co-trimoxazole prophylaxis in HIV-exposed and HIV-infected children in high HIV-prevalence countries.
    Zachariah R; Harries AD; Luo C; Bachman G; Graham SM
    Lancet Infect Dis; 2007 Oct; 7(10):686-93. PubMed ID: 17897611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia.
    Boettiger DC; Sudjaritruk T; Nallusamy R; Lumbiganon P; Rungmaitree S; Hansudewechakul R; Kumarasamy N; Bunupuradah T; Saphonn V; Truong KH; Yusoff NKN; Do VC; Nguyen LV; Razali KAM; Fong SM; Kurniati N; Kariminia A
    J Adolesc Health; 2016 Apr; 58(4):451-459. PubMed ID: 26803201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global Policy Review of Recommendations on Cotrimoxazole Prophylaxis among People Living with HIV.
    Gupta S; Granich R; Hersh B; Lepere P; Samb B
    J Int Assoc Provid AIDS Care; 2014; 13(5):397-401. PubMed ID: 24899258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating prevention of mother-to-child HIV transmission (PMTCT) programmes with other health services for preventing HIV infection and improving HIV outcomes in developing countries.
    Tudor Car L; van-Velthoven MH; Brusamento S; Elmoniry H; Car J; Majeed A; Atun R
    Cochrane Database Syst Rev; 2011 Jun; (6):CD008741. PubMed ID: 21678382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WHO initiatives to increase access to treatment in developing countries.
    Elliott R
    Can HIV AIDS Policy Law Rev; 2002 Dec; 7(2-3):57-8. PubMed ID: 14740603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: Does cotrimoxazole preventive therapy and/or antiretroviral therapy protect against death?
    Tshitenge S; Ogunbanjo GA; Citeya A
    Afr J Prim Health Care Fam Med; 2018 Nov; 10(1):e1-e5. PubMed ID: 30456967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Human Immunodeficiency Virus Drug Resistance on Treatment of Human Immunodeficiency Virus Infection in Children in Low- and Middle-Income Countries.
    Siberry GK; Amzel A; Ramos A; Rivadeneira ED
    J Infect Dis; 2017 Dec; 216(suppl_9):S838-S842. PubMed ID: 29045697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.